Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Miles

Showing results (721-730 of 824) with videos related to

Pageof 83
Sort By:
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2016
Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerasesTimothy J Miles, Alan J Hennessy, Ben Bax, et al.
ACS Infectious Diseases|January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.
JMIR Human Factors|April 9, 2025
Co-Designing a Web-Based and Tablet App to Evaluate Clinical Outcomes of Early Psychosis Service Users in a Learning Health Care Network: User-Centered Design Workshop and Pilot StudyKathleen E Burch, Valerie L Tryon, Katherine M Pierce, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2011
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerasesTimothy J Miles, Jeffrey M Axten, Christopher Barfoot, et al.
The Journal of Biological Chemistry|September 7, 2012
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targetingJulia Ekeruche-Makinde, Mathew Clement, David K Cole, et al.
Journal of Medicinal Chemistry|July 15, 2020
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent <i>In Vitro</i> Antileishmanial Activity: Initial SAR and Assessment of <i>In Vivo</i> ActivityMichael G Thomas, Manu De Rycker, Richard J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2013
Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerasesTimothy J Miles, Alan J Hennessy, Ben Bax, et al.
Pageof 83

Showing results (721-730 of 824) with videos related to

Sort By:
Pageof 83
Nature Immunology|January 17, 2012
Structural basis for the killing of human beta cells by CD8(+) T cells in type 1 diabetesAnna M Bulek, David K Cole, Ania Skowera, et al.
The Journal of Clinical Investigation|October 10, 2018
Bone marrow transplantation generates T cell-dependent control of myeloma in miceSlavica Vuckovic, Simone A Minnie, David Smith, et al.
Bioorganic & Medicinal Chemistry Letters|April 9, 2016
Novel tricyclics (e.g., GSK945237) as potent inhibitors of bacterial type IIA topoisomerasesTimothy J Miles, Alan J Hennessy, Ben Bax, et al.
ACS Infectious Diseases|January 23, 2020
The Q<sub>i</sub> Site of Cytochrome <i>b</i> is a Promiscuous Drug Target in <i>Trypanosoma cruzi</i> and <i>Leishmania donovani</i>Richard J Wall, Sandra Carvalho, Rachel Milne, et al.
Immunity|August 18, 2016
Programmed Death-1 Ligand 2-Mediated Regulation of the PD-L1 to PD-1 Axis Is Essential for Establishing CD4(+) T Cell ImmunityDeshapriya S Karunarathne, Joshua M Horne-Debets, Johnny X Huang, et al.
JMIR Human Factors|April 9, 2025
Co-Designing a Web-Based and Tablet App to Evaluate Clinical Outcomes of Early Psychosis Service Users in a Learning Health Care Network: User-Centered Design Workshop and Pilot StudyKathleen E Burch, Valerie L Tryon, Katherine M Pierce, et al.
Bioorganic & Medicinal Chemistry Letters|November 4, 2011
Novel amino-piperidines as potent antibacterials targeting bacterial type IIA topoisomerasesTimothy J Miles, Jeffrey M Axten, Christopher Barfoot, et al.
The Journal of Biological Chemistry|September 7, 2012
T-cell receptor-optimized peptide skewing of the T-cell repertoire can enhance antigen targetingJulia Ekeruche-Makinde, Mathew Clement, David K Cole, et al.
Journal of Medicinal Chemistry|July 15, 2020
Identification and Optimization of a Series of 8-Hydroxy Naphthyridines with Potent <i>In Vitro</i> Antileishmanial Activity: Initial SAR and Assessment of <i>In Vivo</i> ActivityMichael G Thomas, Manu De Rycker, Richard J Wall, et al.
Bioorganic & Medicinal Chemistry Letters|August 24, 2013
Novel hydroxyl tricyclics (e.g., GSK966587) as potent inhibitors of bacterial type IIA topoisomerasesTimothy J Miles, Alan J Hennessy, Ben Bax, et al.
Pageof 83